Search for: "Wells v. Ortho Pharmaceutical Corp" Results 81 - 100 of 103
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
26 Aug 2009, 5:14 pm
Ortho-McNeil Pharmaceutical v. [read post]
29 Jul 2009, 1:35 pm
Ortho Pharmaceutical Corp. to establish that mere possibility [of causation] alone is insufficient to establish a prima facie case. [read post]
7 May 2009, 6:08 am
Novartis Pharmaceuticals Corp., 252 F.3d 986, 990 (8th Cir. 2001); Hans v. [read post]
20 Mar 2009, 2:05 am
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 354 (Ill. 1996); Woodill v. [read post]
8 Oct 2008, 11:50 am
Ortho Pharmaceutical Corp., 637 F.2d 8, 90-91 (2d Cir. 1980).North Carolina: N.C. [read post]
29 Aug 2008, 1:25 pm
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: CAFC sets strict standards to establish inequitable conduct: Star Scientific v R J Reynolds Tobacco: (Hal Wegner), (Maryland Intellectual Property Law Blog), (Patent Prospector), (Patent Docs), (Patently-O), (more from Patently-O), (Philip Brooks), (Law360), (I/P Updates), Safe harbour ruling in Io v Veoh could help YouTube in Viacom… [read post]
16 Aug 2008, 2:43 am
– discussion of Washington Post article on Ismed’s efforts to promote follow-on biologics approval pathway: (Patent Baristas), (Patent Docs), US: Congressional fact-finding on follow-on biologics: (Patent Docs), US: David v Monsanto: Biotechnology patent ‘exhaustion’ after Quanta, Supreme Court petition: (Hal Wegner), US: Ulysses Pharmaceuticals announces issuance of patent for novel class of ant [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop –… [read post]
22 Jul 2008, 10:42 am
Novartis Pharmaceuticals Corp., 2008 WL 2683047 (E.D. [read post]
28 Apr 2008, 11:00 am
: (Patent Docs), US: Supreme Court declines to hear final Nucleonics’ appeal in gene-silencing patent dispute with Benitec Australia: (IP Law360), (Therapeutics Daily), US: 505(b)(2) drug approvals rock - Interaction of patents and exclusivity of drugs approved by FDA under section 505(b)(2): (Patent Baristas), US: StemCells’ patents survive reexam – StemCells and Neuralstem differ on extent of changes: (Patent Docs), US: StemCells announces issuance of… [read post]
18 Apr 2008, 2:00 am
Lélos Kai Sia EE (and Others) v GlaxoSmithKline AEVE: (IPKat), US: Bio commends Sen Specter for patent reform stance: (Patent Docs), US: USPTO rules on two of four neural stem cell patents in dispute between StemCells Inc and Neuralstem Inc; parties disagree on how extensively claims amended: (IP Law360), (IPBiz), US: Insmed continues fight for generic biologic approval: (GenericsWeb), Pharma & Biotech - Products Cipralex (Escitalopram) –… [read post]
11 Apr 2008, 9:00 am
No problem…: Lundbeck A/S v Generics UK Ltd & Ors: (IPKat), Exelon (Rivastigmine Tartrate) – Dr Reddy’s and Novartis settle Exelon patent dispute: (Therapeutics Daily), GeneMaker – Codon Devices, Blue Heron Biotechnology settle patent suit over gene synthesis platform: (Patent Docs), Glucophage (Metformin) – Depomed settles patent litigation against IVAX: (SmartBrief), (IP Law360), (GenericsWeb), Lexapro… [read post]
7 Feb 2008, 10:46 am
In-house, drug and device companies would do well to ensure that their history and tracking files are well-organized and complete. [read post]